Snowball logo
logo
VNDA_logo

Vanda Pharmaceuticals Inc

VNDA β€’ NASDAQ
$3.94-$0.07Β  (1.75%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
268.7254.4192.6198.8216.1215.7
COGS
25.6324.2817.5711.3113.0415.49
Gross Profit
243.1230.1192.6187.5203.1200.2
Operating Expenses & Income
Operating Income
42.166.329(13.95)(40.66)(151.2)(185.7)
Total Operating Expenses
200.9223.8206.6228.1354.2385.9
R&D Expenses
75.3685.7776.8274.43109.3117
Selling General & Admin Expenses
117.3133.9122.1144.5238263.4
Earnings from Continuing Operations
Interest Expense
(0.199)(4.971)----
Interest Income
------
Income Tax Expense
9.2125.0253.83(4.021)81.8397.65
Net Income
Net Income
33.156.2752.509(18.9)(220.5)(274.9)
Supplemental
EBIT
42.3611.3(13.95)(22.92)(138.6)(180.1)
EBITDA
45.214.03(13.95)(14.79)(126.7)(164.9)
In millions of USD, except % and values per 1 share